drugset / Trial / NCT00793052

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

NCT00793052

Unknown 80 enrolled Tel-Aviv Sourasky Medical Center
NaSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Timeline

Start
2008-11
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg
Subject Etodalac Unknown 600 mg
Subject Etoricoxib Small molecule 120 mg